Amlexanox improves obesity-related metabolic dysfunction in mouse models. It increases thermogenesis and weight loss, decreases steatosis and improves insulin sensitivity. Inhibits TANK-binding kinase 1(TBK1) and IKKԑ (IC50=1.2 µM)². Clinically useful in treatment of aphthus ulsers.
本公司网站所展示销售的产品仅供科研!
沪公网安备 31011202007337号